NHS breast cancer patients to benefit from go ahead for UCL-pioneered treatment

The National Institute for Health and Care Excellence (NICE) has given limited approval for suitable NHS patients to receive a new type of breast cancer treatment pioneered by UCL researchers. Read: Mail on Sunday, More: UCL News